Opening book details…
About this Medicine article
A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma by Nowak, Anna K.; Brown, Chris; Millward, Michael J.; Creaney, Jenette; Byrne, Michael J.; Hughes, Brett; Kremmidiotis, Gabriel; Bibby, David C.; Leske, Annabell F.; Mitchell, Paul L.R.; Pavlakis, Nick; Boyer, Michael; Stockler, Martin R. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Nowak, Anna K.; Brown, Chris; Millward, Michael J.; Creaney, Jenette; Byrne, Michael J.; Hughes, Brett; Kremmidiotis, Gabriel; Bibby, David C.; Leske, Annabell F.; Mitchell, Paul L.R.; Pavlakis, Nick; Boyer, Michael; Stockler, Martin R.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 2013
- Field
- Medicine (Health Sciences)